Glycitan esters of unsaturated fatty acids and their preparation
US-9045447-B2 · Jun 2, 2015 · US
US10358409B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10358409-B2 |
| Application number | US-201514847664-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 8, 2015 |
| Priority date | Sep 15, 2014 |
| Publication date | Jul 23, 2019 |
| Grant date | Jul 23, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions including certain olefinic ester compounds are generally disclosed. In some embodiments, such compositions are compositions having low toxicity, such as low aquatic toxicity. Therefore, in some embodiments, such compositions can be suitable used as solvents or as part of a solvent system for applications where low toxicity is desirable. Such uses include, but are not limited to, cleaning applications on or near waterways, use in oil or gas recovery, and the like. In some other embodiments, such compositions are treatment fluids for oil wells, and can therefore be introduced into an oil well to remove buildup and other deposits. In some embodiments, the olefinic ester compounds are derived from a natural oil or a natural oil derivative.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I): wherein: R 1 is —(CH 2 ) 7 —CH═CH—CH 2 —CH 3 ; R 2 is R 3 or -G 3 -R 3 ; G 3 is —CH 2 — or —CH 2 —CH 2 ; and R 3 is: C 3-12 cycloalkyl, which is optionally substituted with one or more substituents selected from the group consisting of halogen atoms, unsubstituted C 1-4 alkyl groups, C 1-4 fluoroalkyl groups, C 1-4 alkoxy groups, C 1-4 fluoroalkoxy groups, —OH groups, —NH 2 groups, —NH(C 1-4 alkyl) groups, —N(unsubstituted C 1-4 alkyl) 2 groups, —CN groups, —COOH groups, —COO(C 1-4 alkyl) groups, —CONH 2 groups, —CONH(C 1-4 alkyl) groups, —CON(C 1-4 alkyl) 2 groups, —CHO groups, —CO(C 1-4 alkyl) groups, hydroxy- and/or C 1-4 alkoxy-substituted C 1-4 alkyl groups, and any combinations thereof; C 2-20 heterocycloalkyl, which is optionally substituted with one or more substituents selected from the group consisting of halogen atoms, unsubstituted C 1-4 alkyl groups, C 1-4 fluoroalkyl groups, C 1-4 alkoxy groups, C 1-4 fluoroalkoxy groups, —OH groups, —NH 2 groups, —NH(C 1-4 alkyl) groups, —N(C 1-4 alkyl) 2 groups, —CN groups, —COOH groups, —COO(C 1-4 alkyl) groups, —CONH 2 groups, —CONH(C 1-4 alkyl) groups, —CON(C 1-4 alkyl) 2 groups, —CHO groups, —CO(C 1-4 alkyl) groups, hydroxy- and/or C 1-4 alkoxy-substituted C 1-4 alkyl groups, and any combinations thereof; C 6-20 aryl, which is optionally substituted with one or more substituents selected from the group consisting of halogen atoms, unsubstituted C 1-4 alkyl groups, C 1-4 fluoroalkyl groups, C 1-4 alkoxy groups, C 1-4 fluoroalkoxy groups, —OH groups, —NH 2 groups, —NH(C 1-4 alkyl) groups, —N(unsubstituted C 1-4 alkyl) 2 groups, —CN groups, —COOH groups, —COO(C 1-4 alkyl) groups, —CONH 2 groups, —CONH(C 1-4 alkyl) groups, —CON(C 1-4 alkyl) 2 groups, —CHO groups, —CO(C 1-4 alkyl) groups, hydroxy- and/or C 1-4 alkoxy-substituted C 1-4 alkyl groups, and any combinations thereof; or C 3-20 heteroaryl, which is optionally substituted. 2. The compound of claim 1 , wherein R 2 is -G 3 -R 3 . 3. The compound of claim 1 , wherein R 2 is R 3 . 4. The compound of claim 3 , wherein R 3 is C 3-12 cycloalkyl, which is optionally substituted with one or more substituents selected from the group consisting of halogen atoms, unsubstituted C 1-4 alkyl groups, C 1-4 fluoroalkyl groups, C 1-4 alkoxy groups, C 1-4 fluoroalkoxy groups, —OH groups, —NH 2 groups, —NH(C 1-4 alkyl) groups, —N(unsubstituted C 1-4 alkyl) 2 groups, —CN groups, —COOH groups, —COO(C 1-4 alkyl) groups, —CONH 2 groups, —CONH(C 1-4 alkyl) groups, —CON(C 1-4 alkyl) 2 groups, —CHO groups, —CO(C 1-4 alkyl) groups, hydroxy- and/or C 1-4 alkoxy-substituted C 1-4 alkyl groups, and any combinations thereof. 5. The compound of claim 4 , wherein R 3 is cyclopentyl, cyclohexyl, norbornyl, or adamantyl. 6. The compound of claim 5 , wherein R 3 is cyclohexyl. 7. The compound of claim 3 , where R 3 is C 2-2C heterocycloalkyl, which is optionally substituted with one or more substituents selected from the group consisting of halogen atoms, unsubstituted C 1-4 alkyl groups, C 1-4 fluoroalkyl groups, C 1-4 alkoxy groups, C 1-4 fluoroalkoxy groups, —OH groups, —NH 2 groups, —NH(C 1-4 alkyl) groups, —N(C 1-4 alkyl) 2 groups, —CN groups, —COOH groups, —COO(C 1-4 alkyl) groups, —CONH 2 groups, —CONH(C 1-4 alkyl) groups, —CON(C 1-4 alkyl) 2 groups, —CHO groups, —CO(C 1-4 alkyl) groups, hydroxy- and/or C 1-4 alkoxy-substituted C 1-4 alkyl groups, and any combinations thereof. 8. The compound of claim 7 , wherein R 3 is tetrahydrofuranyl, tetrahydropyranyl, or dioxanyl. 9. The compound of claim 3 , wherein R 3 is phenyl. 10. The compound of claim 3 , wherein R 3 is furanyl, oxazolyl, or isoxazolyl.
of acids with a six-membered ring · CPC title
Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring · CPC title
The ring being saturated · CPC title
Monocarboxylic acid esters having only one carbon-to-carbon double bond · CPC title
not condensed with other rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.